Innate Pharma S.A. (IPHA) Reports 1H EPS of EUR0.02

Innate Pharma S.A. (NASDAQ: IPHA) reported 1H EPS of EUR0.02. Revenue for the quarter came in at EUR40.2 million.

For earnings history and earnings-related data on Innate Pharma S.A. (IPHA) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Beike (BEKE) PT Raised to $23 at Morgan Stanley
• Is the global equity rally broadening? UBS weighs in